Clinical TrialsSearch results
Number of results: 237
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2)
- stage III/IV ovarian, tubal and peritoneal carcinomas
- Japan Clinical Oncology Group(JCOG)
- 2005-06-07
Other
- Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer.
- stage III colon cancer including RS cancer
- KSCC
- 2008-10-22
Other
- Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer
- non-small-cell lung cancer
- Lung Oncology Group in Kyushu, Japan (LOGIK)
- 2009-08-25
Other
- Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Evaluation of feasibility and accuracy of diagnosis using sentinel node biopsy in early gastric cancer(JCOG0302, GCSSG-SNB)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Establishment of quality of care among hospitals in digestive surgery
- Patients who underwent elective digestive surgery
- National Hospital Organization Kumamoto Medical Center
- 2008-10-02
Other
- Epidemic Research on Acute Mesenteric Ischemia in Japan
- Acute Mesenteric Ischemia
- National Hospital Organization Kumamoto Medical Center
- 2008-10-01
Other
- Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a prospective cohort study
- A case without informed consent for SURF-RCT among primary hepatocellular carcinoma cases with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Surgery vs. RFA (SURF) trial group
- 2009-04-01